GLP-1 Medications Explained: The $200 Billion Healthcare Revolution

Jan 20, 202643 min

Show Notes

We dive deep into the explosive world of GLP-1 medications—Ozempic, Wegovy, Mounjaro, and Zepbound. From med spa injections to proper medical supervision, this conversation sheds light on what safe GLP-1 treatment should actually look like.

Topics: Weight Management, Medications, Clinical Practice

Timestamps:

  • 00:00 – Introduction: The $200 billion GLP-1 economy
  • 03:15 – Wild West of GLP-1 prescribing: Med spas and strip mall clinics 1
  • 0:42 – Proper patient screening and medical supervision
  • 24:30 – Insurance coverage, pricing, and access issues
  • 32:00 – Tirzepatide vs. Semaglutide: Which is better?
  • 42:55 – The future of GLP-1s and closing thoughts